Search
Cellectis SA
CLLSAdd to Watchlist
1.380USD
+0.270+24.32%
Close 11-11 16:00（ET）
139.01MMarket Cap
LossP/E TTM
After-hours 19:53 (ET)1.460USD+0.110+8.15%
After-hours 19:53 (ET)About Cellectis SA Company
Cellectis SA is a France-based company active in the field of genome engineering and genomic surgery. The Company specializes in the research, development, and commercialization of rational genome engineering technologies. The Company develops immunotherapies that aim to force the immune system to target and eradicate cancer cells. It has developed an expertise in combining meganucleases with engineered targeting Deoxyribonucleic Acid (DNA) matrices into Meganuclease Recombination Systems (MRS), used for gene excision, correction or replacement. Cellectis SA markets its technologies mainly for use in the research field, in pharmaceutical drug discovery programs, in the agronomics, bioproduction, and biotherapeutics fields. Cellectis SA operates several subsidiaries. The Company operates in France and the United States, among others.
Cellectis SA Profile
Ticker SymbolCLLS
Company nameCellectis SA
IPO dateFeb 06, 2007
CEOSourdive (David J.D)
Number of employees224
Security typeDepository Receipt
Fiscal year-endFeb 06
Address8, rue de la Croix Jarry
CityPARIS
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryFrance
Postal code75013
Phone33181691600
Websitehttps://www.cellectis.com/
Ticker SymbolCLLS
IPO dateFeb 06, 2007
CEOSourdive (David J.D)
Company Executives of Cellectis SA
Name
Name/Position
Position
Shareholding
Change
Dr. Steven (Steve) Doares, Ph.D.
Dr. Steven (Steve) Doares, Ph.D.
Senior Vice President - US Manufacturing
Senior Vice President - US Manufacturing
--
--
Mr. Andre C. Muller
Mr. Andre C. Muller
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Tyrell J. Rivers, Ph.D.
Dr. Tyrell J. Rivers, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Marc Dunoyer
Mr. Marc Dunoyer
Non-Executive Director
Non-Executive Director
--
--
Dr. Adrian Kilcoyne, M.D.
Dr. Adrian Kilcoyne, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Cecile Chartier, Ph.D.
Dr. Cecile Chartier, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Axel-Sven Malkomes
Mr. Axel-Sven Malkomes
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Donald A. Bergstrom, M.D., Ph.D.
Dr. Donald A. Bergstrom, M.D., Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Jeanpierre (JP) Garnier, M.D., Ph.D.
Dr. Jeanpierre (JP) Garnier, M.D., Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Ms. Kyung Nam-Wortman
Ms. Kyung Nam-Wortman
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Steven (Steve) Doares, Ph.D.
Dr. Steven (Steve) Doares, Ph.D.
Senior Vice President - US Manufacturing
Senior Vice President - US Manufacturing
--
--
Mr. Andre C. Muller
Mr. Andre C. Muller
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Tyrell J. Rivers, Ph.D.
Dr. Tyrell J. Rivers, Ph.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Marc Dunoyer
Mr. Marc Dunoyer
Non-Executive Director
Non-Executive Director
--
--
Dr. Adrian Kilcoyne, M.D.
Dr. Adrian Kilcoyne, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Cecile Chartier, Ph.D.
Dr. Cecile Chartier, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
FAQs
Who are the top five shareholders of Cellectis SA?
The top five shareholders of Cellectis SA are: Dr. Andre Choulika, Ph.D.
How many institutions hold shares of Cellectis SA (CLLS)?
As of 2026Q1, 77 institutions hold shares of Cellectis SA, with a combined market value of approximately 12.30M, accounting for 17.00% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -5544701.00.